Related Experiment Videos
Alternative venous outflow vessels in microvascular breast reconstruction
Babak J Mehrara1, Timothy Santoro, Andrew Smith
1Department of Surgery, UCLA Medical Center, Los Angeles, CA, USA. mehrarab@mskcc.org
Plastic and Reconstructive Surgery
|August 6, 2003
Summary
The external jugular and cephalic veins offer successful alternative outflow vessels for microvascular breast reconstruction when primary options fail. These ancillary veins improve flap salvage rates and are well-tolerated, with minimal complications.
Area of Science:
- Plastic Surgery
- Microsurgery
- Reconstructive Surgery
Background:
- Microvascular breast reconstruction is often complicated by inadequate recipient vessels post-mastectomy and irradiation.
- Size mismatch in outflow veins contributes significantly to thrombosis and flap failure.
Purpose of the Study:
- To review the authors' experience using alternative venous outflow vessels in microvascular breast reconstruction.
- To evaluate the efficacy and safety of external jugular and cephalic veins as outflow conduits.
Main Methods:
- Retrospective analysis of 1278 microvascular breast reconstructions over 10 years.
- Identification of patients utilizing external jugular or cephalic veins for venous outflow.
- Analysis of patient demographics, flap types, reasons for alternative vessel use, and complication rates.
Main Results:
- External jugular vein used in 23 flaps (22 patients), primarily with superior gluteal and TRAM flaps.
- Cephalic vein used in 11 flaps (11 patients), predominantly with TRAM and superior gluteal flaps.
- Alternative vessels frequently used due to size mismatch (74% for external jugular vein).
- Flap salvage rates were high when using these veins, with low complication incidence (one minor neck hematoma).
Conclusions:
- External jugular and cephalic veins are valuable ancillary options for microvascular breast reconstruction.
- These vessels are straightforward to dissect, well-tolerated, and associated with high success rates.
- Their use can mitigate complications arising from inadequate primary recipient vessels or size mismatches.